A two-year analysis of risk factors and outcome in patients with bloodstream infection

Japanese Journal of Infectious Diseases

Volumn 56, Issue 1, 2003, Pages 1-7

  Endimiani, Andrea ^a   Tamborini, Antonio ^a   Luzzaro, Francesco ^a   Lombardi, Gianluigi ^a   Toniolo, Antonio ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CEFTAZIDIME; CLAVULANIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENTEROBACTERIACEAE; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INDWELLING CATHETER; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; RISK FACTOR; SEPTIC SHOCK; STATISTICAL ANALYSIS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CAUSALITY; COHORT STUDIES; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 0038476209     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Reimer, L. G., Wilson, M. L. and Weinstein, M. P. (1997): Update on detection of bacteremia and fungemia. Clin. Microbiol. Rev., 10, 444-465.
2. DiGiovine, B., Chenoweth, C., Watts, C. and Higgins, M. (1999): The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am. J. Respir. Crit. Care Med., 160, 976-981.
3. Orsi, G. B., Di Stefano, L. and Noah, N. (2002): Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect. Control Hosp. Epidemiol., 23, 190-197.
4. Wenzel, R. P. and Edmond, M. B. (2001): The impact of hospital-acquired bloodstream infections. Emerg. Infect. Dis., 7, 174-177.
5. Pinner, R. W., Teutsh, S. M., Simonsen, L., Klug, L. A., Graber, M. J., Clarke, M. J. and Berkeiman, R. L. (1996): Trends in infectious disease mortality in the United States. JAMA, 275, 189-193.
6. Karchmer, A. W. (2000): Nosocomial bloodstream infections: organisms, risk factors, and implications. Clin. Infect. Dis., 31, 139-143.
7. Pittet, D., Li, N., Woolson, R. F. and Wenzel, R. P. (1997): Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin. Infect. Dis., 24, 1068-1078.
8. Edgeworth, J. D., Treacher, D. F. and Eykyn, S. J. (1999): A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit. Care Med., 27, 1421-1428.
9. Weinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G. and Reller, L. B. (1997): The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis., 24, 584-602.
10. Kaye, K. S., Fraimow, H. S. and Abrutyn, E. (2000): Pathogens resistant to antimicrobial agents. Infect. Dis. Clin. North Am., 14, 293-319.
11. Dunne, W. M., Jr., Nolte, F. S., Wilson, M. L. and Hindler, J. A. (1997): Blood cultures. III. In Cumitech 1B: cumulative techniques and procedures in clinical microbiology. American Society for Microbiology, Washington, D.C.
12. Jarlier, V., Nicolas, M. H., Fournier, G. and Philippon, A. (1988): Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis., 10, 867-878.
13. National Committee for Clinical Laboratory Standards (2000): Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. National Committee for Clinical Laboratory Standards (2000): Performance standards for antimicrobial disk susceptibility tests. 5th ed. Approved standard M2-A7. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. McCabe, W R. and Jackson, G. G. (1962): Gram-negative bacteremia. 1. Etiology and ecology. Arch. Intern. Med., 110, 847-864.
16. Charlson, M. E., Pompei, P., Ales, K. L. and MacKenzie, C. R. (1987): A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic. Dis., 40, 373-383.
17. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992): Definitions of sepsis, organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med., 20, 864-874.
18. Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C. and Hughes, J. M. (1988): CDC definitions for nosocomial infections. Am. J. Infect. Control, 16, 128-140.
19. Bouza, E., Pérez-Molina, J. and Muñoz, P., on behalf of the Cooperative Group of the European Study Group on Nosocomial Infections (ESGNI) (1999): Report of ESGNI-001 and ESGNI-002 studies. Bloodstream infections in Europe. Clin. Microbiol. Infect., 5, 1-12.
20. Brun-Buisson, C., Doyon, F., Carlet, J. and the French Bacteremia-Sepsis Study Group (1996): Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. Am. J. Respir. Crit. Care Med., 154, 617-624.
21. Ronveaux, O., Jans, B., Suetens, C. and Carsauw, H. (1998): Epidemiology of nosocomial bloodstream infections in Belgium, 1992-1996. Eur. J. Clin. Microbiol. Infect. Dis., 17, 695-700.
22. Rojo, D., Pinedo, A., Clavijo, E., Garcia-Rodriguez, A. and Garcia, V. (1999): Analysis of risk factors associated with nosocomial bacteremias. J. Hosp. Infect., 42, 135-141.
23. Garrouste-Orgeas, M., Chevret, S., Mainardi, J. L., Timsit, J. F., Misset, B. and Carlet, J. (2000): A one-year prospective study of nosocomial bacteremia in ICU and non-ICU patients and its impact on patient outcome. J. Hosp. Infect., 44, 206-213.